Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for right ventricular hypertrophy in lung disease-associated pulmonary hypertension
2014-002305-38Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of allopurinol in pulmonary hypertension (PH) and right ventricular hypertrophy (RVH) (2 arms), sponsored by University of Dundee. Primary endpoint: Change in right ventricular mass index. Started Dec 2014; status: completed.
02
Drugs
allopurinol
03
Conditions
pulmonary hypertension (PH)right ventricular hypertrophy (RVH)
Beyond the preview
Go deeper on 2014-002305-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002305-38.